|
US3536809A
(en)
*
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
*
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
BE757436A
(fr)
*
|
1969-10-27 |
1971-03-16 |
Robins Co Inc A H |
1-carbamoyl-4-phenyl-piperidines et -tetrahydropyridines, leur procede de preparation et leurs applications comme anticonvulsivants et relaxants musculaires
|
|
US3845770A
(en)
*
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
*
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
*
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
IE58110B1
(en)
*
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
DE3440141A1
(de)
|
1984-11-02 |
1986-05-07 |
Heiner Dipl.-Chem. Dr. 8000 München Eckert |
Verwendung von kohlensaeure-bis-trichlormethylester als proreagens fuer phosgen
|
|
JPH0680054B2
(ja)
|
1985-06-19 |
1994-10-12 |
吉富製薬株式会社 |
ピペリジン誘導体
|
|
US5316759A
(en)
*
|
1986-03-17 |
1994-05-31 |
Robert J. Schaap |
Agonist-antagonist combination to reduce the use of nicotine and other drugs
|
|
US4797419A
(en)
*
|
1986-11-03 |
1989-01-10 |
Warner-Lambert Company |
Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
|
|
US5198459A
(en)
*
|
1987-07-11 |
1993-03-30 |
Sandoz Ltd. |
Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
|
|
DE3822792C2
(de)
*
|
1987-07-11 |
1997-11-27 |
Sandoz Ag |
Neue Verwendung von 5HT¶3¶-Antagonisten
|
|
US5506191A
(en)
*
|
1987-11-02 |
1996-04-09 |
Sandoz Ltd. |
Heterocyclic hydrazines and hydrazones
|
|
US5073543A
(en)
*
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
*
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5075341A
(en)
*
|
1989-12-01 |
1991-12-24 |
The Mclean Hospital Corporation |
Treatment for cocaine abuse
|
|
US5733566A
(en)
*
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5698155A
(en)
*
|
1991-05-31 |
1997-12-16 |
Gs Technologies, Inc. |
Method for the manufacture of pharmaceutical cellulose capsules
|
|
US6204284B1
(en)
*
|
1991-12-20 |
2001-03-20 |
American Cyanamid Company |
Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
|
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5232934A
(en)
*
|
1992-07-17 |
1993-08-03 |
Warner-Lambert Co. |
Method for the treatment of psychomotor stimulant addiction
|
|
DE4234295A1
(de)
*
|
1992-10-12 |
1994-04-14 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US5321012A
(en)
*
|
1993-01-28 |
1994-06-14 |
Virginia Commonwealth University Medical College |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
|
|
IT1270594B
(it)
*
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5556837A
(en)
*
|
1994-08-01 |
1996-09-17 |
Regeneron Pharmaceuticals Inc. |
Methods for treating addictive disorders
|
|
US5762925A
(en)
*
|
1994-11-03 |
1998-06-09 |
Sagen; Jacqueline |
Preventing opiate tolerance by cellular implantation
|
|
ATE301457T1
(de)
*
|
1995-06-12 |
2005-08-15 |
Searle & Co |
Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
|
|
PL193686B1
(pl)
*
|
1995-09-07 |
2007-03-30 |
Hoffmann La Roche |
Pochodne piperydyny, środki lecznicze zawierającepochodne piperydyny, sposoby wytwarzania tych pochodnych oraz zastosowanie pochodnych
|
|
FR2740134B1
(fr)
|
1995-10-18 |
1998-01-09 |
Pf Medicament |
Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant
|
|
FR2744448B1
(fr)
*
|
1996-02-02 |
1998-04-24 |
Pf Medicament |
Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
|
|
CA2274593A1
(en)
*
|
1996-12-13 |
1998-06-18 |
Banyu Pharmaceutical Co., Ltd. |
Novel aminopyrazole derivatives
|
|
FR2758328B1
(fr)
*
|
1997-01-15 |
1999-04-02 |
Pf Medicament |
Nouvelles amines aromatiques derivees d'amines cycliques utiles comme medicaments
|
|
JP4444493B2
(ja)
*
|
1997-08-20 |
2010-03-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
カプサイシン受容体およびカプサイシン受容体関連ポリペプチドをコードする核酸配列ならびにその使用
|
|
EP0943683A1
(en)
*
|
1998-03-10 |
1999-09-22 |
Smithkline Beecham Plc |
Human vanilloid receptor homologue Vanilrep1
|
|
WO1999065896A1
(en)
|
1998-06-19 |
1999-12-23 |
Eli Lilly And Company |
Preparation of heteroaryl compounds
|
|
ES2151828B1
(es)
*
|
1998-07-10 |
2001-08-16 |
Esteve Labor Dr |
Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor.
|
|
WO2000017163A1
(en)
|
1998-09-22 |
2000-03-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
Cyanophenyl derivatives
|
|
SE9803773D0
(sv)
|
1998-11-05 |
1998-11-05 |
Astra Pharma Prod |
Compounds
|
|
ATE240316T1
(de)
|
1998-12-23 |
2003-05-15 |
Lilly Co Eli |
Heteroaromatische amide als inhibitoren von faktor xa
|
|
WO2000042852A1
(en)
|
1999-01-25 |
2000-07-27 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
GB9907097D0
(en)
*
|
1999-03-26 |
1999-05-19 |
Novartis Ag |
Organic compounds
|
|
WO2000069816A1
(en)
*
|
1999-05-17 |
2000-11-23 |
Eli Lilly And Company |
Metabotropic glutamate receptor antagonists
|
|
WO2001017965A2
(en)
*
|
1999-09-07 |
2001-03-15 |
Syngenta Participations Ag |
Cyanopiperidines as pesticides
|
|
EP1272187B1
(de)
|
2000-03-27 |
2008-07-30 |
Abbott GmbH & Co. KG |
Dopamin-d3-rezeptor-liganden zur behandlung von sucht
|
|
PT1285651E
(pt)
*
|
2000-04-28 |
2010-10-21 |
Takeda Pharmaceutical |
Antagonistas da hormona concentradora da melanina
|
|
DZ3347A1
(fr)
|
2000-05-22 |
2001-11-29 |
Aventis Pharma Inc |
Dérivés d'arylméthylamine pour leur utilisation comme inhibiteurs de la tryptase
|
|
RU2251419C2
(ru)
*
|
2000-06-21 |
2005-05-10 |
Ф. Хоффманн-Ля Рош Аг |
Производные бензотиазола
|
|
EP1313477A4
(en)
|
2000-07-15 |
2004-03-03 |
Smithkline Beecham Corp |
COMPILATIONS AND METHODS
|
|
IL153884A0
(en)
|
2000-07-20 |
2003-07-31 |
Neurogen Corp |
Capsaicin receptor ligands
|
|
EP1437344A4
(en)
*
|
2001-09-28 |
2006-09-20 |
Takeda Pharmaceutical |
BENZENE DERIVATIVES AND PROCESS FOR THE PREPARATION AND USE THEREOF
|
|
EP1458385A4
(en)
*
|
2001-12-19 |
2005-12-21 |
Merck & Co Inc |
METABOTROPIC GLUTAMATE RECEPTOR 5-HETEROARYL-SUBSTITUTED IMIDAZOLE MODULATORS
|
|
US7390813B1
(en)
*
|
2001-12-21 |
2008-06-24 |
Xenon Pharmaceuticals Inc. |
Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
|
|
AU2003212882A1
(en)
*
|
2002-02-01 |
2003-09-02 |
Euro-Celtique S.A. |
2 - piperazine - pyridines useful for treating pain
|
|
ATE416168T1
(de)
|
2002-02-15 |
2008-12-15 |
Glaxo Group Ltd |
Modulatoren des vanilloidrezeptors
|
|
US6974818B2
(en)
*
|
2002-03-01 |
2005-12-13 |
Euro-Celtique S.A. |
1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
|
|
GB0209715D0
(en)
*
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
US20030232836A1
(en)
*
|
2002-05-23 |
2003-12-18 |
Stewart Andrew O. |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
|
WO2003099266A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Abbott Laboratories |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
|
DK1522314T3
(da)
|
2002-06-26 |
2014-05-26 |
Ono Pharmaceutical Co |
Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
|
|
DE60318875T2
(de)
*
|
2002-06-28 |
2009-01-15 |
Euro-Celtique S.A. |
Therapeutische piperazin-derivate für die behandlung von schmerzen
|
|
US7262194B2
(en)
|
2002-07-26 |
2007-08-28 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
US7157462B2
(en)
*
|
2002-09-24 |
2007-01-02 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
DE10252666A1
(de)
*
|
2002-11-11 |
2004-08-05 |
Grünenthal GmbH |
N-Piperidyl-cyclohexan-Derivate
|
|
US7582635B2
(en)
*
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
|
DE10306250A1
(de)
*
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US7223788B2
(en)
*
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
|
US7067509B2
(en)
*
|
2003-03-07 |
2006-06-27 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
|
DE10311065A1
(de)
*
|
2003-03-13 |
2004-09-23 |
Abbott Gmbh & Co. Kg |
Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
|
|
US20060217371A1
(en)
|
2003-04-28 |
2006-09-28 |
Olivier Bezencon |
Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors
|
|
ATE556067T1
(de)
*
|
2003-05-20 |
2012-05-15 |
Ajinomoto Kk |
Modulatoren des vanilloid rezeptors
|
|
AR044688A1
(es)
*
|
2003-06-12 |
2005-09-21 |
Euro Celtique Sa |
Agentes terapeuticos utiles para el tratamiento del dolor
|
|
US7129235B2
(en)
*
|
2003-07-11 |
2006-10-31 |
Abbott Laboratories |
Amides useful for treating pain
|
|
US20050009841A1
(en)
*
|
2003-07-11 |
2005-01-13 |
Zheng Guo Zhu |
Novel amides useful for treating pain
|
|
EP1648878B9
(en)
*
|
2003-07-24 |
2011-03-16 |
Euro-Celtique S.A. |
Piperidine compounds and pharmaceutical compositions containing them
|
|
ES2327684T3
(es)
|
2003-07-24 |
2009-11-02 |
Euro-Celtique S.A. |
Compuestos heteroaril-tetrahidropiridilo utiles para el tratamiento o la prevencion del dolor.
|
|
WO2005011654A2
(en)
*
|
2003-07-29 |
2005-02-10 |
Xenon Pharmaceuticals Inc. |
Pyridyl derivatives and their use as therapeutic agents
|
|
KR20060037409A
(ko)
*
|
2003-07-30 |
2006-05-03 |
제논 파마슈티칼스 인크. |
피페라진 유도체 및 그의 치료제로서의 용도
|
|
KR20060037410A
(ko)
*
|
2003-07-30 |
2006-05-03 |
제논 파마슈티칼스 인크. |
피리다진 유도체 및 그의 치료제로서의 용도
|
|
MXPA06001331A
(es)
*
|
2003-08-01 |
2006-05-04 |
Euro Celtique Sa |
Agentes terapeuticos utiles para el tratamiento del dolor.
|
|
SI1664041T1
(sl)
*
|
2003-09-22 |
2008-12-31 |
Euro Celtique Sa |
Fenil-karboksamidne spojine, uporabne za tretiranje bolečine
|
|
US20050130974A1
(en)
*
|
2003-10-17 |
2005-06-16 |
Rigel Pharmaceuticals, Inc. |
Benzothiazole compositions and their use as ubiquitin ligase inhibitors
|
|
AU2004293026B2
(en)
*
|
2003-11-21 |
2012-01-19 |
Array Biopharma Inc. |
AKT protein kinase inhibitors
|